But too often, health care organizations do not control the distribution of medication samples, with manufacturer representatives organizing sample closets for their own benefits, physicians failing to record who got what or to properly instruct patients on how to take their drugs, and pharmacists ...
The value of pharmaceutical representative visits and medication samples in community-based family practices 来自 NCBI 喜欢 0 阅读量: 27 作者:EL Backer,JA Lebsack,RJV Tonder,BF Crabtree 摘要: Interactions between the pharmaceutical industry and physicians have been discussed in numerous publications; ...
Using the same sample, it was found that meeting criteria for a substance use disorder was associated with an almost twofold risk of also meeting criteria for an anxiety disorder. Analysis of two more population samples – the National Comorbidity Survey and the Ontario Health Survey, from the ...
Clinical management of patients with chronic cardiometabolic disease is complicated by polypharmacy. Consequently, when patients clinically deteriorate, physicians are challenged to distinguish both medication nonadherence and drug-drug interactions (DDI
Medicare beneficiaries and free prescription drug samples: a national survey J Gen Intern Med (2008) L.D. Chew et al. A physician survey of the effect of drug sample availability on physicians' behavior J Gen Int Med (2000) R.V. Gibbons et al. A comparison of physicians' and patients'...
For this purpose, blood and urine samples of athletes are collected and analysed. In 2006 approximately 200,000 samples were analysed worldwide, with 1.96% being tested positive. All physicians should be aware of the possibility that athletes use medication subjected to the doping regulations. ...
A review of self-medication in physicians and medical students. Occup Med (Chic Ill). 2011;61(7):490–497. doi:10.1093/occmed/kqr098 10. Murray MD, Callahan CM. Improving medication use for older adults: an integrated research agenda. Ann Intern Med. 2003;139 (5_Part_2):425–429. ...
2 However, use of medications for breast cancer risk reduction is low in clinical practice7-9 because of women’s concerns about adverse effects and beliefs that benefits are not worth the harms,3 difficulty in identifying candidates for therapy, and primary care physicians’ unfamiliarity with ...
18. Zaugg V, Korb-Savoldelli V, Durieux P, Sabatier B, Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication: Cochrane Database Syst Rev, 2018; 1(1); CD012042 19. Chaudri NA, Adherence to long-term therapies evidence for act...
We will organize a closing event for the involved physicians to present and discuss the project results. Discussion This protocol presents the design of a randomized controlled trial to evaluate the efficacy of a tailored intervention to improve medication adherence in elderly patients with PD. The ...